Role of CD4^+CD28^-T cell subset in patients with Systemic Lupus Erythematosus
CD4^CD28^-T细胞亚群在系统性红斑狼疮患者中的作用
基本信息
- 批准号:07670547
- 负责人:
- 金额:$ 1.54万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Systemic lupus erythematosus (SLE) is characterized by B cell hyperactivity and defects of immunoregulatory T cells. CD28 antigen is an accessory molecule, that transduces a potent costimulatory signal for cell activation, and is expressed on the vast majority of CD4_+ T cells. It has been reported that CD4_+CD28_- T cells were refractory to anergy induction and showed sustained reactivity to the self antigen, suggesting involvement of CD4_+CD28_- T cells in the pathogenesis of autoimmune diseases. We found that CD4_+ CD28_- T cells are prevalent in peripheral blood in patients with SLE.This T cell subset expressed HLA-DR,IL-2 receptor, VLAbeta chain brightly, indicating that this subset locates in a late stage of T cell activation cascade. We found that CD4_+ CD28_- T cells exhibited oligoclonal expansion of the selected clones. In addition, CD4_+ CD28_- T cells produced large amounts of IL-6 spontaneously. These results suggest that SLE CD4_+CD28_- T cells have been activated by unidentified, possibly self, antigen in vivo and participate in the pathogenesis of human SLE.
全身性红斑狼疮(SLE)的特征是B细胞多动和免疫调节T细胞的缺陷。 CD28抗原是一种辅助分子,可传递有效的costimulation信号,以用于细胞激活,并在绝大多数CD4_+ T细胞上表达。据报道,CD4_+CD28_- T细胞对厌食诱导是难治性的,并显示出对自抗原的持续反应性,这表明CD4_+CD28_- T细胞参与了自身免疫性疾病的发病机理。我们发现SLE患者的外周血中CD4_+ CD28_- T细胞在外周血中普遍存在。该T细胞子集表达HLA-DR,IL-2受体,Vlabeta链明亮,表明该子集位于T细胞活化级联的晚期。我们发现CD4_+ CD28_- T细胞表现出所选克隆的寡克隆膨胀。此外,CD4_+ CD28_- T细胞自发产生大量IL-6。这些结果表明,SLE CD4_+CD28_- T细胞已通过体内未鉴定的,可能是自我抗原激活,并参与了人SLE的发病机理。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Suzuki,T.et.al.: "Low serum levels of dehydroepiandrosterone may cause deficient interleukin-2 production by lymphocytes in patients with systemic luous erythematosus." Clinical and Experimental lmmunology. 99. 251-255 (1995)
Suzuki, T.et.al.:“低血清脱氢表雄酮水平可能导致系统性红斑狼疮患者淋巴细胞产生白细胞介素 2 不足。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takeno,M. et. al.: "Autoreactive T cell clones from patients with SLE support polyclonal autoantibody production." The Journal of Immunology. (in press). (1997)
武野,M.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Suzuki,N.et.al.: "Hormones and Lupus : Defective dehydroepiandrosterone activity induces impaired interleukin-2 activity of T lymphocytes in patients with systemic lupus erythematosus." Annales de Medicine lnterne. 147. 248-252 (1996)
Suzuki,N.et.al.:“激素与狼疮:脱氢表雄酮活性缺陷会导致系统性红斑狼疮患者 T 淋巴细胞的白细胞介素 2 活性受损。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
脇坂季繁,他.: "2.全身性の自己免疫疾患(2)全身性エリテマトーデス自己免疫でおこる難治性疾患-実地医家のための最新情報-(坂根剛編)" 医薬ジャーナル社.(印刷中), (1997)
胁坂岸重等:《2.系统性自身免疫性疾病(2)由自身免疫性引起的难治性疾病——系统性红斑狼疮-执业医师的最新信息-(坂根刚编)》医药期刊株式会社(印刷) ),(1997)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
坂根剛、他: "膠原病の見方と新しい治療:免疫から見た膠原病" 臨床と研究. 72. 798-803 (1995)
Tsuyoshi Sakane 等人:“胶原蛋白疾病和新疗法的观点:从免疫角度来看胶原蛋白疾病”临床与研究 72. 798-803 (1995)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUZUKI Noboru其他文献
SUZUKI Noboru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUZUKI Noboru', 18)}}的其他基金
Fabrication of Capsule Reactor Type Artificial Photosynthesis System for the Direct Formation of Methanol from CO2
CO2直接生成甲醇胶囊反应器型人工光合作用系统的研制
- 批准号:
24310052 - 财政年份:2012
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Differentiation of retinal progenitors derived from ES cells and iPS cells.
来自 ES 细胞和 iPS 细胞的视网膜祖细胞的分化。
- 批准号:
22591969 - 财政年份:2010
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of molecular mechanisms involving with the generation and the pathological condition of rhabdomyosarcoma induced by genetic recombination specifically in skeletal muscle
骨骼肌基因重组诱导横纹肌肉瘤发生及病理状态的分子机制分析
- 批准号:
20590276 - 财政年份:2008
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Txk functions in the development of Th1 cells and its application for treatment of autoimmune and allergic diseases
Txk在Th1细胞发育中的功能分析及其在自身免疫和过敏性疾病治疗中的应用
- 批准号:
14370166 - 财政年份:2002
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of RAG expression in antibody-secreting B cell of SLE patients
SLE患者抗体分泌B细胞RAG表达分析
- 批准号:
12470116 - 财政年份:2000
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Role of dehydroepiandrosterone deficiency for the impaired interleukin 2 production of T cells in human systemic lupus erythematosus
脱氢表雄酮缺乏对人类系统性红斑狼疮 T 细胞白细胞介素 2 生成受损的作用
- 批准号:
04670398 - 财政年份:1992
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions
由 DNA 折纸和干扰肽组成的新混合分子模式作为蛋白质-蛋白质相互作用的抑制剂
- 批准号:
10578747 - 财政年份:2021
- 资助金额:
$ 1.54万 - 项目类别:
New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions
由 DNA 折纸和干扰肽组成的新混合分子模式作为蛋白质-蛋白质相互作用的抑制剂
- 批准号:
10173147 - 财政年份:2021
- 资助金额:
$ 1.54万 - 项目类别:
New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions
由 DNA 折纸和干扰肽组成的新混合分子模式作为蛋白质-蛋白质相互作用的抑制剂
- 批准号:
10378010 - 财政年份:2021
- 资助金额:
$ 1.54万 - 项目类别:
Probes to target the 3-way hotspot of IL1RacP to abolish aberrant interleukin inflammation
靶向 IL1RacP 3 路热点以消除异常白细胞介素炎症的探针
- 批准号:
9085212 - 财政年份:2015
- 资助金额:
$ 1.54万 - 项目类别:
Probes to target the 3-way hotspot of IL1RacP to abolish aberrant interleukin inflammation
靶向 IL1RacP 3 路热点以消除异常白细胞介素炎症的探针
- 批准号:
8944833 - 财政年份:2015
- 资助金额:
$ 1.54万 - 项目类别: